中文 
别名:26S proteasome non-ATPase regulatory subunit 13, 26S proteasome regulatory subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory subunit p405, PSMD13应用:WB,IHC,FCM
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| PSMD13 acts as a regulatory subunit of the 26S proteasome which is involved in the ATP-dependent degradation of ubiquitinated proteins. |
| Specification | |
|---|---|
| Aliases | 26S proteasome non-ATPase regulatory subunit 13, 26S proteasome regulatory subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory subunit p405, PSMD13 |
| Entrez GeneID | 5719 |
| Swissprot | Q9UNM6 |
| WB Predicted band size | 42.9kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This PSMD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 269-298 amino acids from the C-terminal region of human PSMD13. |
| Formulation | Purified polyclonal antibody supplied in PBS with 0.05% sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
| Application | |
|---|---|
| WB | 1/1000 |
| IHC | 1/100-1/500 |
| FCM | 1/10-1/50 |
 |
Anti-PSMD13 Antibody (C-term) at 1:1000 dilution + Jurkat whole cell lysate
Lysates/proteins at 20 µg per lane. Secondary Predicted band size : 43 kDa Blocking/Dilution buffer: 5% NFDM/TBST. |
 |
Western blot analysis of PSMD13 Antibody (C-term) (Cat. #P34192) in Y79 cell line lysates (35ug/lane). PSMD13 (arrow) was detected using the purified Pab. |
 |
PSMD13 Antibody (C-term) (Cat. #P34192) flow cytometric analysis of 293 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. |
 |
Formalin-fixed and paraffin-embedded human lung carcinoma reacted with PSMD13 Antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复